Recent Updates
Recently added Catalysts
SCNX Neutral Sentiment Score: 60/100

Trxade health, Inc files its 3Q 10Q TAMPA, FL

Key Takeaway: TRxADE Health, Inc. has filed its Quarterly Report on Form 10-Q for the period ending September 30, 2023. The company received a notice from Nasdaq about noncompliance for not filing timely but believes it has regained compliance following the report submission. The article also discusses potential risks and uncertainties affecting TRxADE, including legal proceedings and funding challenges.

Market Sentiment Analysis

POSITIVE FACTORS

  • TRxADE has filed its Quarterly Report on Form 10-Q, suggesting compliance efforts.
  • The company believes it has regained compliance with Nasdaq Listing Rule 5250(c)(1).

CONCERNS & RISKS

  • The company initially received a notice of noncompliance from Nasdaq for late filing.
  • There are ongoing risks and uncertainties mentioned in the forward-looking statements.

Full Press Release Details

Trxade health, Inc files its 3Q 10Q
FL, January 17, 2024 (GLOBE NEWSWIRE) - TRxADE HEALTH, INC. (NASDAQ: MEDS) ("TRxADE"), a parent company of pharmaceutical
business-to-business exchange platform, announced today that it filed its Quarterly Report on Form 10-Q for the period ended September
30, 2023 (the "Form 10-Q").
November 21, 2023, the Company received a standard notice of noncompliance from the Nasdaq Listing Qualifications Department ("Nasdaq")
indicating that, as a result of not having timely filed its Form 10-Q, the Company was not in compliance with Nasdaq Listing Rule 5250(c)(1),
which requires timely filing of all required periodic financial reports with the Securities and Exchange Commission.
Company believes it has now regained compliance with Nasdaq Listing Rule 5250(c)(1) with the filing of its Form 10-Q.
Health, Inc. is a parent company with various subsidiaries which include the pharmaceutical marketplace https://rx.trxade.com,
plant-based food www.superlatus.com.
statements in this press release are "forward-looking statements" within the meaning of Section 27A of the Securities Act
of 1933, Section 21E of the Securities Exchange Act of 1934, and as that term is defined in the Private Securities Litigation Reform
Act of 1995. TRxADE intends that such forward-looking statements be subject to the safe harbors created thereby. Forward-looking statements
relate to future events or TRxADE's future performance or future financial condition. These forward-looking statements are not
historical facts but rather are based on current expectations, estimates, and projections about TRxADE, its industry, beliefs, and assumptions.
Such forward-looking statements include, but are not limited to, statements regarding TRxADE's or TRxADE's management team's
expectations, hopes, beliefs, intentions, or strategies regarding the future, including TRxADE splans for and the potential benefits
of the supplier agreement and the products, markets, and expected future performance and market opportunities of TRxADE. In addition,
any statements that refer to projections, forecasts, or other characterizations of future events or circumstances, including any underlying
assumptions, are forward-looking statements. In some cases, you can identify forward-looking statements by the following words: "anticipate,"
"believe," "continue," "could," "estimate," "expect," "intend,"
"may," "ongoing," "plan," "potential," "predict," "project,"
"should," or the negative of these terms or other similar expressions, but the absence of these words does not mean that
a statement is not forward-looking. Forward-looking statements are subject to a number of risks and uncertainties (some of which are
beyond TRxADE's control) that may cause actual results or performance to be materially different from those expressed or implied
by such forward-looking statements. Accordingly, readers should not place undue reliance on any forward-looking statements. These risks
include risks relating to agreements with third parties; TRxADE's ability to raise funding in the future, as needed, and the terms
of such funding, including potential dilution caused thereby; TRxADE's ability to continue as a going concern; security interests
under certain of TRxADE's credit arrangements; TRxADE's ability to maintain the listing of its common stock on The Nasdaq
Capital Market; claims relating to alleged violations of intellectual property rights of others; the outcome of any current legal proceedings
or future legal proceedings that may be instituted against TRxADE; unanticipated difficulties or expenditures relating to TRxADE's
business plan; and those risks detailed in TRxADE's most recent Annual Report on Form 10-K and subsequent reports filed with the
Securities and Exchange Commission. Forward-looking statements speak only as of the date they are made. TRxADE undertakes no obligation
to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise that occur after
that date, except as otherwise provided by law.
Corporate Communications Group, LLC
Scott Powell, President
One Rockefeller Plaza, 11th Floor
Office: (646) 893-5835

Frequently Asked Questions

What did TRxADE Health file on January 17, 2024?

TRxADE Health, Inc. filed its Quarterly Report on Form 10-Q for Q3 2023.

What notice did TRxADE receive from Nasdaq?

TRxADE received a notice of noncompliance for not timely filing its Form 10-Q.

How does TRxADE believe it regained compliance?

TRxADE believes it regained compliance by filing its Form 10-Q.

What does TRxADE's forward-looking statements include?

They include expectations about TRxADE's future performance and market opportunities.

What are the risks of TRxADE's forward-looking statements?

Risks include funding challenges and potential legal proceedings affecting performance.

Last updated: Jan 17, 2024